2003
DOI: 10.1016/j.jaci.2003.09.031
|View full text |Cite
|
Sign up to set email alerts
|

Current management of atopic dermatitis and interruption of the atopic march

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
43
0

Year Published

2004
2004
2019
2019

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 67 publications
(44 citation statements)
references
References 113 publications
(114 reference statements)
1
43
0
Order By: Relevance
“…These would include treatment of patients who are poorly responsive to topical steroids or have steroid phobia, and treatment of face and neck dermatitis where ineffective, low-potency topical corticosteroids are usually used due to fears of steroid-induced skin atrophy. The potential use of topical calcineurin inhibitors as maintenance therapy is also intriguing for prevention of AD flares and progression of the atopic march (28,29). However, although systemic absorption of these compounds is low, there is a need for careful surveillance to rule out the possibility that skin cancers and increased viral skin infections will appear when such agents are used long-term.…”
Section: Factors Contributing To Flares Of Admentioning
confidence: 99%
“…These would include treatment of patients who are poorly responsive to topical steroids or have steroid phobia, and treatment of face and neck dermatitis where ineffective, low-potency topical corticosteroids are usually used due to fears of steroid-induced skin atrophy. The potential use of topical calcineurin inhibitors as maintenance therapy is also intriguing for prevention of AD flares and progression of the atopic march (28,29). However, although systemic absorption of these compounds is low, there is a need for careful surveillance to rule out the possibility that skin cancers and increased viral skin infections will appear when such agents are used long-term.…”
Section: Factors Contributing To Flares Of Admentioning
confidence: 99%
“…In several short-term studies, tacrolimus ointment has been shown to be an effective treatment for AD in adults and children [30, 31, 33, 34, 84]. Patients treated with tacrolimus ointment, 0.03 and 0.1% applied twice daily for up to 6 weeks showed improvement in outcomes such as modified EASI and Investigator Global AD Assessment.…”
Section: Clinical Experience With Topical Calcineurin Inhibitorsmentioning
confidence: 99%
“…Neonates with infantile eczema had a significantly higher number and ratio of eosinophils in the cord blood (eosinophil count: 670. 8 tions develop atopic dermatitis, an initial manifestation of atopic march [8,9] . However, it is still obscure what types of skin eruptions are associated with the subsequent development of atopic dermatitis and why [8,[10][11][12][13] .…”
Section: Introductionmentioning
confidence: 99%